157 related articles for article (PubMed ID: 10523018)
1. Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.
Valve R; Sivenius K; Miettinen R; Pihlajamäki J; Rissanen A; Deeb SS; Auwerx J; Uusitupa M; Laakso M
J Clin Endocrinol Metab; 1999 Oct; 84(10):3708-12. PubMed ID: 10523018
[TBL] [Abstract][Full Text] [Related]
2. Effect of the Pro12Ala polymorphism in the peroxisome proliferator-activated receptor (PPAR) gamma2 gene on the expression of PPARgamma target genes in adipose tissue of massively obese subjects.
Kolehmainen M; Uusitupa MI; Alhava E; Laakso M; Vidal H
J Clin Endocrinol Metab; 2003 Apr; 88(4):1717-22. PubMed ID: 12679463
[TBL] [Abstract][Full Text] [Related]
3. The Pro12Ala polymorphism of the PPAR gamma 2 gene regulates weight from birth to adulthood.
Pihlajamäki J; Vanhala M; Vanhala P; Laakso M
Obes Res; 2004 Feb; 12(2):187-90. PubMed ID: 14981210
[TBL] [Abstract][Full Text] [Related]
4. Relationship of PPARgamma2 polymorphism with obesity and metabolic syndrome in postmenopausal Polish women.
Milewicz A; Tworowska-Bardziñska U; Dunajska K; Jêdrzejuk D; Lwow F
Exp Clin Endocrinol Diabetes; 2009 Nov; 117(10):628-32. PubMed ID: 19609844
[TBL] [Abstract][Full Text] [Related]
5. A genetic polymorphism of the peroxisome proliferator-activated receptor gamma gene influences plasma leptin levels in obese humans.
Meirhaeghe A; Fajas L; Helbecque N; Cottel D; Lebel P; Dallongeville J; Deeb S; Auwerx J; Amouyel P
Hum Mol Genet; 1998 Mar; 7(3):435-40. PubMed ID: 9467001
[TBL] [Abstract][Full Text] [Related]
6. [Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in the PPARgamma gene?].
Bidzińska B; Demissie M; Tworowska U; Slezak R; Dobosz T; Milewicz A
Pol Merkur Lekarski; 2004 Oct; 17(100):361-4. PubMed ID: 15690702
[TBL] [Abstract][Full Text] [Related]
7. [Leptin level and the PPARgamma2 Pro12Ala and Pro115Gln polymorphisms in women with functional hyperandrogenism. Preliminary report].
Bidzińska-Speichert B; Demissie M; Tworowska U; Slezak R; Dobosz T; Bednarek-Tupikowska G; Milewicz A
Przegl Lek; 2005; 62(9):833-7. PubMed ID: 16541712
[TBL] [Abstract][Full Text] [Related]
8. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
González Sánchez JL; Serrano Ríos M; Fernández Perez C; Laakso M; Martínez Larrad MT
Eur J Endocrinol; 2002 Oct; 147(4):495-501. PubMed ID: 12370112
[TBL] [Abstract][Full Text] [Related]
9. Effects of two common polymorphisms of peroxisome proliferator-activated receptor-gamma gene on metabolic syndrome.
Rhee EJ; Oh KW; Lee WY; Kim SY; Oh ES; Baek KH; Kang MI; Kim SW
Arch Med Res; 2006 Jan; 37(1):86-94. PubMed ID: 16314192
[TBL] [Abstract][Full Text] [Related]
10. [Association of Pro12Ala variant in peroxisome proliferator-activated receptor-gamma2 gene with type 2 diabetes mellitus].
Fu M; Chen H; Li X; Li J; Wu B; Cheng L; Cai M; Fu Z
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2002 Jun; 19(3):234-8. PubMed ID: 12048686
[TBL] [Abstract][Full Text] [Related]
11. Exon 6 and 2 peroxisome proliferator-activated receptor-gamma polymorphisms in polycystic ovary syndrome.
Orio F; Matarese G; Di Biase S; Palomba S; Labella D; Sanna V; Savastano S; Zullo F; Colao A; Lombardi G
J Clin Endocrinol Metab; 2003 Dec; 88(12):5887-92. PubMed ID: 14671186
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptor gamma 2 Pro12Ala gene variant is strongly associated with larger body mass in the Taiwanese.
Lei HH; Chen MH; Yang WS; Chiu MC; Chen MC; Tai TY; Chuang LM
Metabolism; 2000 Oct; 49(10):1267-70. PubMed ID: 11079814
[TBL] [Abstract][Full Text] [Related]
13. [Is obesity associated with a polymorphism Pro12Ala and Pro115Gln in PPARgamma gene?].
Bidzińska B; Demissie M; Tworowska U; Slezak R; Dobosz T; Milewicz A
Pol Merkur Lekarski; 2004 May; 16(95):434-7. PubMed ID: 15518421
[TBL] [Abstract][Full Text] [Related]
14. Association of the PRO12ALA polymorphism of the PPAR-gamma2 gene with oxidized low-density lipoprotein and cardiolipin autoantibodies in nondiabetic and type 2 diabetic subjects.
Niskanen L; Lindi V; Erkkilä A; Sivenius K; Luoma J; Ylä-Herttuala S; Laakso M; Uusitupa MI
Metabolism; 2003 Feb; 52(2):213-7. PubMed ID: 12601635
[TBL] [Abstract][Full Text] [Related]
15. Relationship between peroxisome proliferator-activated receptor gamma and retinoic acid receptor alpha gene expression in obese human adipose tissue.
Redonnet A; Bonilla S; Noël-Suberville C; Pallet V; Dabadie H; Gin H; Higueret P
Int J Obes Relat Metab Disord; 2002 Jul; 26(7):920-7. PubMed ID: 12080444
[TBL] [Abstract][Full Text] [Related]
16. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y
Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694
[TBL] [Abstract][Full Text] [Related]
17. The Pro12Ala polymorphism in PPAR gamma2 may confer resistance to type 2 diabetes.
Hara K; Okada T; Tobe K; Yasuda K; Mori Y; Kadowaki H; Hagura R; Akanuma Y; Kimura S; Ito C; Kadowaki T
Biochem Biophys Res Commun; 2000 Apr; 271(1):212-6. PubMed ID: 10777704
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD
Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843
[TBL] [Abstract][Full Text] [Related]
19. [Association of Pro12Ala mutation in peroxisome proliferator-activated receptor gamma 2 with obesity and diabetes in Chinese population].
Wang C; Zhai F; Chi Y; Wang G
Wei Sheng Yan Jiu; 2004 May; 33(3):317-20. PubMed ID: 15211802
[TBL] [Abstract][Full Text] [Related]
20. Effect of the Ala12 allele in the PPARgamma-2 gene on the relationship between birth weight and body composition in adolescents: the AVENA study.
Labayen I; Moreno LA; Marti A; González-Lamuño D; Wärnberg J; Ortega FB; Bueno G; Nova E; Ruiz JR; Garagorri JM; Martínez JA; García-Fuentes M; Bueno M;
Pediatr Res; 2007 Nov; 62(5):615-9. PubMed ID: 17805195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
